Ranbaxys Asia Pacific

Rediff.com » News » Ranbaxys Asia Pacific

News for Ranbaxys Asia Pacific

News
Business

Is India losing its key ally?

India is failing to take advantage of its important ally, Japan as much as it should, notes Mihir S Sharma. India's most important bilateral relationship may not be with the United States, or......

Sun-Ranbaxy merger clears last hurdle

The merger gets Punjab & Haryana High Court go-ahead; deal to close after brand dilutions The $4-billion merger between Sun Pharmaceutical Industries and Ranbaxy Laboratories has crossed the final......

Sun gets US trade regulator nod for Ranbaxy merger

Gujarat-based Torrent also in the fray for India assets Drug major Sun Pharma is now a step closer to becoming the world’s fifth-largest generic drug company, as the US Federal Trade......

Sun-Ranbaxy merger may spill over to 2015

The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region Sun......

Sun Pharma to buy Ranbaxy in $3.2-billion deal

India's Sun Pharmaceutical Industries Ltd has agreed to buy generic drugmaker Ranbaxy Laboratories Ltd for $3.2 billion, betting it can fix factory quality glitches that plagued the current owner,......

Markets slump as high interest rates may prevail

Markets snapped a four-day winning streak on Friday with rate sensitive leading the decline after comments from Reserve Bank of India Governor Raghuram Rajan late Thursday commented that inflation......

Rediff News

Ranbaxys Asia Pacific

News for Ranbaxys Asia Pacific

Is India losing its key ally?

Sun-Ranbaxy merger clears last hurdle

Sun gets US trade regulator nod for Ranbaxy merger

Sun-Ranbaxy merger may spill over to 2015

Sun Pharma to buy Ranbaxy in $3.2-billion deal

Markets slump as high interest rates may prevail

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS